STRO icon

Sutro Biopharma
STRO

Overview Fund Activity

32 hedge funds and large institutions have $137M invested in Sutro Biopharma in 2018 Q3 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
32
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SHI
1
SV Health Investors
Massachusetts
$27.4M
2
Citadel Advisors
2
Citadel Advisors
Florida
$26.2M
3
EAM
3
Eventide Asset Management
Massachusetts
$18.1M
4
CCM
4
Camber Capital Management
Massachusetts
$9M
5
CI
5
Cowen Inc
New York
$6.26M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
DCM
26
DAFNA Capital Management
California
$412K +$412K +27,494 New
AGM
27
Alpine Global Management
New York
$375K +$375K +25,000 New
Walleye Trading
28
Walleye Trading
New York
$319K +$319K +21,263 New
Walleye Capital
29
Walleye Capital
New York
$201K +$201K +13,395 New
BCM
30
BlueCrest Capital Management
Jersey
$165K +$165K +11,000 New
Victory Capital Management
31
Victory Capital Management
Texas
$90K +$90K +6,000 New
UBS Group
32
UBS Group
Switzerland
$19K +$19K +1,248 New
CCA
33
Catalyst Capital Advisors
New York
$8K +$8K +500 New
1
2